Prostatis Group LLC has filed its 13F form on March 21, 2025 for Q4 2024 where it was disclosed a total value porftolio of $343 Billion distributed in 155 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Invesco Qqq Trust, Series 1 with a value of $34.6B, Spdr Dow Jones Industrial Average ETF Trust with a value of $17.9B, Spdr Bloomberg 1 3 Month T Bil with a value of $16.3B, Spdr S&P 500 ETF Trust with a value of $16.2B, and Amplify ETF Tr Amplify Cwp Enh with a value of $13.5B.

Examining the 13F form we can see an increase of $37.4B in the current position value, from $306B to 343B. Also it can be appreciated an additional of 24 stocks purchases and 3 closed positions.

Prostatis Group LLC is based out at Hanover, MD

Below you can find more details about Prostatis Group LLC portfolio as well as his latest detailed transactions.

Portfolio value $343 Billion
ETFs: $260 Billion
Technology: $16.5 Billion
Consumer Cyclical: $15.1 Billion
Communication Services: $8.7 Billion
Financial Services: $6.44 Billion
Industrials: $6.15 Billion
Healthcare: $3.27 Billion
Consumer Defensive: $2.56 Billion
Other: $4.46 Billion

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 155
  • Current Value $343 Billion
  • Prior Value $306 Billion
  • Filing
  • Period Q4 2024
  • Filing Date March 21, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 24 stocks
  • Additional Purchases 68 stocks
  • Sold out of 3 stocks
  • Reduced holdings in 60 stocks
Track This Portfolio

Track Prostatis Group LLC Portfolio

Follow Prostatis Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prostatis Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prostatis Group LLC with notifications on news.